BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23850743)

  • 1. Validation of a human cell based high-throughput genotoxicity assay 'Anthem's Genotoxicity screen' using ECVAM recommended lists of genotoxic and non-genotoxic chemicals.
    Rajakrishna L; Krishnan Unni S; Subbiah M; Sadagopan S; Nair AR; Chandrappa R; Sambasivam G; Sukumaran SK
    Toxicol In Vitro; 2014 Feb; 28(1):46-53. PubMed ID: 23850743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase-reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development.
    Westerink WM; Stevenson JC; Horbach GJ; Schoonen WG
    Mutat Res; 2010 Feb; 696(1):21-40. PubMed ID: 20006733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells.
    Mizota T; Ohno K; Yamada T
    Mutat Res; 2011 Sep; 724(1-2):76-85. PubMed ID: 21704725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
    Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: validation of the GreenScreen HC GADD45a-GFP genotoxicity assay.
    Hastwell PW; Chai LL; Roberts KJ; Webster TW; Harvey JS; Rees RW; Walmsley RM
    Mutat Res; 2006 Sep; 607(2):160-75. PubMed ID: 16781187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxins.
    Liu X; Kramer JA; Swaffield JC; Hu Y; Chai G; Wilson AG
    Mutat Res; 2008 May; 653(1-2):63-9. PubMed ID: 18485802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive DsRed fluorescence-based reporter cell systems for genotoxicity and oxidative stress assessment.
    Hendriks G; Atallah M; Raamsman M; Morolli B; van der Putten H; Jaadar H; Tijdens I; Esveldt-van Lange R; Mullenders L; van de Water B; Vrieling H
    Mutat Res; 2011 May; 709-710():49-59. PubMed ID: 21382384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a panel of high-throughput reporter-gene assays to detect genotoxicity and oxidative stress.
    van der Linden SC; von Bergh AR; van Vught-Lussenburg BM; Jonker LR; Teunis M; Krul CA; van der Burg B
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Jan; 760():23-32. PubMed ID: 24362253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests.
    Birrell L; Cahill P; Hughes C; Tate M; Walmsley RM
    Mutat Res; 2010 Jan; 695(1-2):87-95. PubMed ID: 20006735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cellular biosensor system for genotoxicity detection based on Trp53 promoter.
    Siqian L; Lei S; Ying L
    Hum Exp Toxicol; 2016 Oct; 35(10):1102-7. PubMed ID: 26721909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a higher throughput screening approach to genotoxicity testing using the GADD45a-GFP GreenScreen HC assay.
    Knight AW; Birrell L; Walmsley RM
    J Biomol Screen; 2009 Jan; 14(1):16-30. PubMed ID: 19171918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to assess the mutagenic potential of cosmetic products without animal tests?
    Speit G
    Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of high-throughput genotoxicity assay screening using γH2AX in-cell western assay on HepG2 cells.
    Khoury L; Zalko D; Audebert M
    Environ Mol Mutagen; 2013 Dec; 54(9):737-46. PubMed ID: 24105934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a high-content screening in vitro micronucleus assay in CHO-k1 and HepG2 cells.
    Westerink WM; Schirris TJ; Horbach GJ; Schoonen WG
    Mutat Res; 2011 Sep; 724(1-2):7-21. PubMed ID: 21658468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests.
    Kirkland D; Kasper P; Martus HJ; Müller L; van Benthem J; Madia F; Corvi R
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 795():7-30. PubMed ID: 26774663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxicity screening via the γH2AX by flow assay.
    Smart DJ; Ahmedi KP; Harvey JS; Lynch AM
    Mutat Res; 2011 Oct; 715(1-2):25-31. PubMed ID: 21824484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the DNA damaging potential of environmental chemicals using a quantitative high-throughput screening approach to measure p53 activation.
    Witt KL; Hsieh JH; Smith-Roe SL; Xia M; Huang R; Zhao J; Auerbach SS; Hur J; Tice RR
    Environ Mol Mutagen; 2017 Aug; 58(7):494-507. PubMed ID: 28714573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the GreenScreen GADD45alpha-GFP indicator assay with non-proprietary and proprietary compounds.
    Olaharski A; Albertini S; Kirchner S; Platz S; Uppal H; Lin H; Kolaja K
    Mutat Res; 2009 Jan; 672(1):10-6. PubMed ID: 18812235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.